Meclofenamate Sodium Capsule
NDC Package 0378-3000-01
Package Information
Meclofenamate Sodium capsules is meclofenamate is used to relieve pain from various conditions (such as headache, muscle aches) and to decrease pain and blood loss from menstrual periods. This formulation utilizes a capsule delivery system. Marketed by Mylan Pharmaceuticals Inc., this product is identified by NDC 0378-3000 and is authorized under FDA application ANDA071081.
Identification & Billing
- RxCUI: 618552 - meclofenamate sodium 100 MG Oral Capsule
- RxCUI: 618552 - meclofenamate 100 MG Oral Capsule
- RxCUI: 618552 - meclofenamate (as meclofenamate sodium) 100 MG Oral Capsule
- RxCUI: 618557 - meclofenamate sodium 50 MG Oral Capsule
- RxCUI: 618557 - meclofenamate 50 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0378 - Mylan Pharmaceuticals Inc.
- 0378-3000 - Meclofenamate Sodium
- 0378-3000-01 - 100 CAPSULE in 1 BOTTLE, PLASTIC
- 0378-3000 - Meclofenamate Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0378-3000-01 identifies a specific commercial package of 100 capsule in 1 bottle, plastic of Meclofenamate Sodium, a human prescription drug labeled by Mylan Pharmaceuticals Inc.. This capsule is formulated for oral use and contains meclofenamate sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mylan Pharmaceuticals Inc. on September 03, 1986. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Meclofenamate is used to relieve pain from various conditions (such as headache, muscle aches) and to decrease pain and blood loss from menstrual periods. It is also used to reduce fever and reduces pain, swelling, and joint stiffness caused by arthritis, bursitis, and gout attacks. Meclofenamate is a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.
How is this Mylan Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00378300001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.